Addex - ADXN Expected earnings per share growth for next year
The expected EPS growth for the coming year reflects the current market valuation of Addex Therapeutics (ADXN) potential. Strict temperature control during the delivery of test drugs increases costs but ensures safety. Meanwhile, 0.00 expresses the metric's value today. Addex Therapeutics (ADXN) is implementing ESG standards in its laboratories, although the development of allosteric modulators is temporarily increasing R&D expenses due to the absence of commercial sales.
addextherapeutics.com - analytical breakdowns and key metrics (ADXN)
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization information:
- debt burden and liquidity indicators:
Debt to Equity Addex Therapeutics|ADXN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Addex Therapeutics Ltd|ADXN - Company Aggregate Debts|Debt to Book Capitalization Ratio Addex Therapeutics|ADXN - Long-Term Liabilities|Company Short-Term Debts Addex Therapeutics|Quick Liquidity Indicator addextherapeutics.com
- earnings and valuation multiples information:
ADXN - Net Profit|Future Profit Addex Therapeutics|ADXN - Market Price to Net Income Ratio|Forward P/E Multiple Addex Therapeutics|ADXN - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Addex Therapeutics|ADXN - Operating profit before deduction of amortization|Earnings per share for the last twelve months Addex Therapeutics|ADXN - Net earnings per share for the last four quarters|Quarterly EPS earnings growth addextherapeutics.com|ADXN - Earnings growth in current year|Earnings growth forecast for next year Addex Therapeutics
Basic company analysis:ADXN, Addex Therapeutics, Ltd.
This indicator measures the expected dynamics of net earnings per share, reflecting the issuer's ability to generate cash flow while accounting for future costs and debt load. By analyzing the forward one-year projected growth of net earnings per share with a value of 0.00, investors assess the monetization potential of the unique allosteric modulation platform of Addex Therapeutics (ADXN), which provides significant pricing power in the development of safe neurological drugs.
Who Addex Therapeutics competes with
Expected earnings per share growth for next year BIIB|NBIX: Expected earnings per share trend next year|Expected earnings per share growth for next year RGC (Regencell Bioscience)|Projected earnings per share increase next year AXSM|Earnings growth forecast for next year ACAD (ACADIA Pharmaceuticals Inc.)|Expected earnings per share trend next year XENE|Viking Pharma - Earnings growth forecast for next year|Expected net earnings per share growth next year Supernus Corp|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|denalitherapeutics.com - Expected earnings per share trend next year|HRMY (Harmony Biosciences Holdings, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Biohaven Ltd|Net earnings per share growth forecast for next year Amylyx (AMLX)|TRVI: Net earnings per share change forecast for next year|Earnings growth forecast for next year PRAX (Praxis Precision Medicines)|anavex.com (AVXL) - Expected net earnings per share growth next year|CBLL: Expected earnings per share growth for next year|PRTA - Earnings growth forecast for next year|ALEC (alector.com) - Expected earnings per share growth for next year|ANNX: Projected earnings per share increase next year|OMER (Omeros Corp) - Earnings growth forecast for next year|neurogene.com (NGNE) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ACIU|Expected earnings per share growth for next year Voyager Therapeutics Inc VYGR|Net earnings per share growth forecast for next year Neumora Therapeutics Inc NMRA|Consensus forecast of earnings per share growth for next year Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings - Earnings growth forecast for next year|ACOG - Earnings growth forecast for next year|CGTX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year IKT|Expected earnings per share growth for next year SAVA|Projected earnings per share growth rate for next year ASRT (Assertio Therapeutics)|Net earnings per share growth forecast for next year Coya Therapeutics, Inc. (COYA)|vistagen.com - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|ABOS: Projected earnings per share growth rate for next year|CervoMed Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Alterity Therapeutics|CLNN (clene.com) - Expected earnings per share growth for next year|PepGen (PEPG) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|RLMD: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Annovis Bio Corp (ANVS)|GRCE - Expected net earnings per share growth next year|Earnings growth forecast for next year AIFF (Firefly Neuroscience, Inc)|Earnings growth forecast for next year ANEW Medical KLTO|NeuroSense Therapeutics, Ltd. - Earnings growth forecast for next year|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Projected earnings per share growth rate for next year|MTVA: Earnings growth forecast for next year|Projected earnings per share growth rate for next year NRXS|HSDT (Helius Medical Technologies, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Passage Bio Corp PASG|Expected earnings per share growth for next year NEUP (Neuphoria Therapeutics Inc.)|Minerva Neurosciences Inc - Projected earnings per share growth rate for next year|Athira - Expected earnings per share growth for next year|Expected earnings per share trend next year ALZN|CYCN: Expected earnings per share growth for next year|Protagenic Therapeutics - Projected earnings per share increase next year|KTTA: Earnings growth forecast for next year|Cortigent - Expected earnings per share trend next year|ATXI (Avenue Therapeutics, Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year BrainStorm Cell Therapeutics Inc. BCLI|Net earnings per share growth forecast for next year Cara Therapeutics, Inc. (CARA)|CHRO (chromocell.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ELYM (Eliem Therapeutics Inc.)|Earnings growth forecast for next year Intra-Cellular Therapies Inc. ITCI|LBPH - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year MRNS|NKGN: Earnings growth forecast for next year|Expected net earnings per share growth next year neurobopharma.com (NRBO)|Expected earnings per share growth for next year SAGE|Earnings growth forecast for next year Synaptogenix Inc.|Expected earnings per share growth for next year TRVN (Trevena, Inc)|Projected earnings per share increase next year VIGL|Earnings growth forecast for next year WENA (Anew Medical)|Consensus forecast of earnings per share growth for next year cerevel.com (CERE)
